Boston Scientific Corp


Want a discount? Become a member by purchasing Annual Subscription!
SKU: BSX Category:


Boston Scientific Corporation: Axonics & Other Acquisitions Are Potential Game Changers? 


Boston Scientific Corporation experienced an exceptional performance in 2023, delivering one of the strongest years in the company’s history by surpassing set financial goals. Throughout the year, total company operational sales grew by 15% and organic sales by 14%, exceeding the high-end guidance range of 8% to 10%. Operational sales growth for the full year was registered at 13%, and organic sales grew by 12%. Amidst impressive results, all regions recorded double-digit growth for both the fourth quarter and the full year 2023, reflecting the company’s effective category leadership strategy.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!